240 related articles for article (PubMed ID: 30584170)
41. Genetics of Parkinson's disease and parkinsonism.
Douglas MR; Lewthwaite AJ; Nicholl DJ
Expert Rev Neurother; 2007 Jun; 7(6):657-66. PubMed ID: 17563249
[TBL] [Abstract][Full Text] [Related]
42. Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
Sutherland GT; Halliday GM; Silburn PA; Mastaglia FL; Rowe DB; Boyle RS; O'Sullivan JD; Ly T; Wilton SD; Mellick GD
Mov Disord; 2009 Apr; 24(6):833-8. PubMed ID: 19224617
[TBL] [Abstract][Full Text] [Related]
43. Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus.
Tatura R; Kraus T; Giese A; Arzberger T; Buchholz M; Höglinger G; Müller U
Parkinsonism Relat Disord; 2016 Dec; 33():115-121. PubMed ID: 27717584
[TBL] [Abstract][Full Text] [Related]
44. Pathogenic mutations in Parkinson disease.
Tan EK; Skipper LM
Hum Mutat; 2007 Jul; 28(7):641-53. PubMed ID: 17385668
[TBL] [Abstract][Full Text] [Related]
45. Unravelling the genetic links between Parkinson's disease and lung cancer.
Leong YQ; Koh RY; Chye SM; Ng KY
Biol Chem; 2023 May; 404(6):551-567. PubMed ID: 36634094
[TBL] [Abstract][Full Text] [Related]
46. Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2.
Bras J; Guerreiro R; Ribeiro M; Morgadinho A; Januario C; Dias M; Calado A; Semedo C; Oliveira C; Hardy J; Singleton A
BMC Neurol; 2008 Jan; 8():1. PubMed ID: 18211709
[TBL] [Abstract][Full Text] [Related]
47. Clinical genetics of Parkinson's disease and related disorders.
Wider C; Wszolek ZK
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
[TBL] [Abstract][Full Text] [Related]
48. Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements.
Scarciolla O; Brancati F; Valente EM; Ferraris A; De Angelis MV; Valbonesi S; Garavaglia B; Uncini A; Palka G; Stuppia L; Dallapiccola B
Mov Disord; 2007 Nov; 22(15):2274-8. PubMed ID: 17914726
[TBL] [Abstract][Full Text] [Related]
49. A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease.
Nishioka K; Kefi M; Jasinska-Myga B; Wider C; Vilariño-Güell C; Ross OA; Heckman MG; Middleton LT; Ishihara-Paul L; Gibson RA; Amouri R; Ben Yahmed S; Ben Sassi S; Zouari M; El Euch G; Farrer MJ; Hentati F
J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):391-5. PubMed ID: 19726410
[TBL] [Abstract][Full Text] [Related]
50. Genetic basis of Parkinson disease.
Xiromerisiou G; Dardiotis E; Tsimourtou V; Kountra PM; Paterakis KN; Kapsalaki EZ; Fountas KN; Hadjigeorgiou GM
Neurosurg Focus; 2010 Jan; 28(1):E7. PubMed ID: 20043722
[TBL] [Abstract][Full Text] [Related]
51. Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.
Macedo MG; Verbaan D; Fang Y; van Rooden SM; Visser M; Anar B; Uras A; Groen JL; Rizzu P; van Hilten JJ; Heutink P
Mov Disord; 2009 Jan; 24(2):196-203. PubMed ID: 18973254
[TBL] [Abstract][Full Text] [Related]
52. Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population.
Diez-Fairen M; Benitez BA; Ortega-Cubero S; Lorenzo-Betancor O; Cruchaga C; Lorenzo E; Samaranch L; Carcel M; Obeso JA; Rodriguez-Oroz MC; Aguilar M; Coria F; Pastor MA; Pastor P
Neurobiol Aging; 2018 Oct; 70():325.e1-325.e5. PubMed ID: 29887346
[TBL] [Abstract][Full Text] [Related]
53. What genetics tells us about the causes and mechanisms of Parkinson's disease.
Corti O; Lesage S; Brice A
Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209
[TBL] [Abstract][Full Text] [Related]
54. Parkinson's disease in a dish - Using stem cells as a molecular tool.
Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
[TBL] [Abstract][Full Text] [Related]
55. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
[TBL] [Abstract][Full Text] [Related]
56. Mendelian forms of Parkinson's disease.
Gasser T
Biochim Biophys Acta; 2009 Jul; 1792(7):587-96. PubMed ID: 19168133
[TBL] [Abstract][Full Text] [Related]
57. Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.
Moura KC; Junior MC; de Rosso AL; Nicaretta DH; Pereira JS; José Silva D; Santos-Rebouças CB; Pimentel MM
Dis Markers; 2012; 32(3):173-8. PubMed ID: 22377733
[TBL] [Abstract][Full Text] [Related]
58. [Genetics and present therapy options in Parkinson's disease: a review].
Bereznai B; Molnar MJ
Ideggyogy Sz; 2009 May; 62(5-6):155-63. PubMed ID: 19579663
[TBL] [Abstract][Full Text] [Related]
59. The Landscape of Monogenic Parkinson's Disease in Populations of Non-European Ancestry: A Narrative Review.
Koros C; Bougea A; Simitsi AM; Papagiannakis N; Angelopoulou E; Pachi I; Antonelou R; Bozi M; Stamelou M; Stefanis L
Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003040
[TBL] [Abstract][Full Text] [Related]
60. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
